<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph principles="no" id="IFRS03_IE93"><paranum>IE93</paranum><prolog><data name="standard_number" value="IFRSÂ 3"/><data name="paranum" value="IE93"/></prolog><body><p id="IFRS03_IE93_P0001">An entity (Purchaser) purchases a legal entity (Entity Biotech). Entity Biotech&#x2019;s operations include: research and development activities on several drug compounds that it is developing (in-process research and development projects); senior management and scientists who have the necessary skills, knowledge, or experience to perform research and development activities; and tangible assets (including a corporate headquarters, a research lab, and lab equipment). Entity Biotech does not yet have a marketable product and has not yet generated revenue. Each of the assets acquired has a similar fair value.</p></body></paragraph>